C4 Therapeutics, Inc. (CCCC)
3.17
+0.32
(+11.23%)
USD |
NASDAQ |
Oct 09, 16:00
3.17
0.00 (0.00%)
After-Hours: 16:55
C4 Therapeutics Net Income (Quarterly) : -23.64M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -23.64M |
| March 31, 2026 | -25.13M |
| December 31, 2025 | -20.49M |
| September 30, 2025 | -32.17M |
| June 30, 2025 | -26.02M |
| March 31, 2025 | -26.32M |
| December 31, 2024 | -34.57M |
| September 30, 2024 | -24.67M |
| June 30, 2024 | -17.72M |
| March 31, 2024 | -28.36M |
| December 31, 2023 | -34.75M |
| September 30, 2023 | -27.04M |
| June 30, 2023 | -35.92M |
| March 31, 2023 | -34.78M |
| Date | Value |
|---|---|
| December 31, 2022 | -37.18M |
| September 30, 2022 | -31.96M |
| June 30, 2022 | -27.41M |
| March 31, 2022 | -31.62M |
| December 31, 2021 | -15.66M |
| September 30, 2021 | -24.68M |
| June 30, 2021 | -22.58M |
| March 31, 2021 | -20.97M |
| December 31, 2020 | -21.80M |
| September 30, 2020 | -21.84M |
| June 30, 2020 | -10.79M |
| March 31, 2020 | -11.91M |
| December 31, 2019 | -10.02M |
| September 30, 2019 | -10.09M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | -106.63M |
| Arrowhead Pharmaceuticals, Inc. | -178.92M |
| Oncolytics Biotech, Inc. | -9.442M |
| Sangamo Therapeutics, Inc. | -31.00M |
| Sarepta Therapeutics, Inc. | -4.89M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 6.641M |
| Total Expenses (Quarterly) | 30.28M |
| EPS Diluted (Quarterly) | -0.1808 |
| Enterprise Value | 153.48M |
| Gross Profit Margin (Quarterly) | 73.05% |
| Profit Margin (Quarterly) | -355.9% |
| Earnings Yield | -31.51% |
| Normalized Earnings Yield | -28.24 |